Start Here

Fast answer

Choose a path, then go deeper.

PRN is meant to be a research publication first. The best use of the site is to start with the guide or standard that matches your question, then use the daily feed for what changed recently.

New to peptide research

Learn the landscape first

Start with the core guide library, then use evidence labels to separate clinical medicines from investigational or research-use compounds.

Browse peptide guides →Supplier due diligence

Check testing before links

Understand COAs, HPLC, mass spectrometry, batch identity and research-use labeling before comparing any supplier.

Read the COA guide →Canada-specific questions

Use the Canada hub

Canadian readers need different regulatory, prescription and supplier context than U.S. telehealth pages usually provide.

Open Canada guide →GLP-1 research and access

Separate clinical care from research chemicals

Semaglutide and tirzepatide are prescription medicines; research-use peptide supplier pages are a separate topic.

Explore GLP-1 →Fresh studies

Go to PubMed-backed research

Use the research feed for new papers, then rely on PRN guide pages for context, evidence strength and regulatory caveats.

Browse research →Want the weekly summary

Get the Peptide Research Brief

The important studies, regulatory changes and commercial developments in one short weekly email.

Get the Brief →